|
Volumn 6, Issue 7, 1996, Pages 627-644
|
New approaches to the treatment of vancomycin-resistant bacterial infections
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMINOGLYCOSIDE ANTIBIOTIC AGENT;
AMPICILLIN;
AZLOCILLIN;
CHLOROORIENTICIN A;
CIPROFLOXACIN;
COTRIMOXAZOLE;
DALFOPRISTIN PLUS QUINUPRISTIN;
DAPTOMYCIN;
GENTAMICIN;
GLYCOPEPTIDE;
NOVOBIOCIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RAMOPLANIN;
RIFAMPICIN;
TEICOPLANIN;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
BACTERIAL INFECTION;
CLINICAL TRIAL;
COAGULASE NEGATIVE STAPHYLOCOCCUS;
DRUG CHOICE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG MIXTURE;
ENTEROCOCCUS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MINIMUM INHIBITORY CONCENTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PATENT;
REVIEW;
|
EID: 0029943294
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.6.7.627 Document Type: Review |
Times cited : (5)
|
References (0)
|